ARCA Discovery Changes Name to ARCA biopharma to Reflect Focus on Drug Commercialization
Company Appoints Randall St. Laurent as EVP of Commercial Operations
DENVER, March 28 /PRNewswire/ -- ARCA
Discovery, Inc., a privately held
company, today announced that it has changed its name to ARCA
effective immediately. In support of the commercial transformation, ARCA
XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca
NEW YORK, Oct. 10 /PRNewswire/ -- HealthShares(TM) Inc., an investment
company with a family of 20 fund portfolios, today announced its Board of
Directors has approved the transfer of its 19 currently NYSE-listed
HealthShares exchange-traded funds (ETFs) to the NYSE Arca
NASCAR Fans Boost Blood Donations; The American Red Cross Joins 3M and Greg Biffle to Kick off Season Two
...an, Erik Darnell and Colin Braun; and three in the Craftsman Truck Series with Darnell, Braun, Kvapil, John Wes Townley and Bobby East; and one in the arca
RE/MAX Series with Ricky Stenhouse Jr. For more information on any of the Roush Fenway Racing teams, log onto www.RoushFenway.com . For sponsorship...
Nuvelo Reports Third Quarter 2008 Financial Results
...-- Entered into a definitive merger agreement with arca
Inc., expected to create a late-stage c...teers.
"We believe that the proposed merger with arca
brings both immediate
and longer-term value to our...ill remain focused on closing the transaction with arca
to drive our clinical programs fo...
Defined Health Announces Final Speaker Roster and Agenda for Therapeutic Insight 2008
... Jeffrey M. Bockman, PhD, Vice President, Defined Health * Michael R. Bristow, MD, PhD, Founder, Chairman and Chief Science and Medical Officer, arca
Discovery * Leslie J. Browne, PhD, President & CEO, Pharmacopeia Inc. * Shannon Brownlee, Schwartz Senior Fellow, New American Foundation * Mich...
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...rterly rebalancing of the Indexes.
The following securities will be added and deleted in the Indexes
effective before the opening of trading on NYSE arca
March 24, 2008.
Autoimmune-Inflammation Index (HHA) Drop GW Pharmaceuticals, Inc (LSE: GWP.L) Human Genome Sciences (Nasdaq: HGSI ) Ligand...
3M Donates Two Full Paint Schemes to American Red Cross for the 2008 NASCAR Sprint Cup Season
...ffle, Edwards, McMurray, Ragan, Erik Darnell and Colin Braun; three in
the Craftsman Truck Series with Darnell, Braun and Joey Clanton; and one in
RE/MAX Series with Ricky Stenhouse, Jr. For more information on
any of the Roush Fenway Racing teams, log onto http://www.RoushFenway.com . For
ARCA in Medical Technology
ARCA in Biological Technology
Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma
SAN CARLOS, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Nuvelo, Inc.
(Nasdaq: NUVO ) today announced that the stockholders of Nuvelo have approved
the issuance of Nuvelo Common Stock pursuant to the merger agreement dated
September 24, 2008, as amended, between Nuvelo, ARCA
biopharma and a Nuve...
Nuvelo and ARCA biopharma Advance Toward Completion of Merger
SAN CARLOS, Calif. and BROOMFIELD, Colo., Dec. 1 /PRNewswire-FirstCall/ --
Nuvelo, Inc. (Nasdaq: NUVO ) and ARCA
biopharma, Inc., a privately-held
biopharmaceutical company developing genetically-targeted therapies for heart
failure and other cardiovascular diseases, today announced that a speci...
Nuvelo and ARCA biopharma Announce Merger Agreement Creating Late-Stage Cardiovascular Biotechnology Company
Experienced Cardiovascular Team to Commercialize First Genetically-Targeted Heart Failure Treatment and Develop Short-Acting Anticoagulant
Webcast Conference Call Scheduled for Thursday, September 25, 2008 at 8:30 a.m. EDT
SAN CARLOS, Calif. and BROOMFIELD, Co...
FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma
BROOMFIELD, Colo., Sept. 23 /PRNewswire/ -- ARCA
announced today that the U.S. Food and Drug Administration (FDA) has
accepted a New Drug Application (NDA) for the company's lead product
candidate, bucindolol, an investigational and pharmacologically unique
beta-blocker and mil...
Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value
...ason to fear this, because most recent mergers involving companies similarly situated to Avigen (e.g., Transcept Pharmaceuticals, Inc., Anesiva, Inc., arca
biopharma, Inc., Evotec Aktiengesellschaft, Cardiovascular Systems, Inc. and others), managed to destroy stockholder value. In each of these transacti...
ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference
...N CARLOS, Calif., Jan. 8 /PRNewswire-FirstCall/ -- arca
biopharma, Inc., a biopharmaceutical company devel...y 14, 2009, at 9:30.a.m. PT in San Francisco.
biopharma and Nuvelo, Inc. announced on September ... the presentation will be available online via the arca
biopharma website at http://www.arcabiopharma.com...
Nuvelo Announces Positive Results from Phase 1 Clinical Trial of NU206 in Healthy Volunteers
... "Because Nuvelo is in the process of merging with arca
create a cardiovascular-focused compa...of the proposed merger
transaction between Nuvelo, arca
biopharma, Inc., or ARCA, and Dawn
Acquisition Sub...ecurities Act of 1933, as amended.
and their respective directors and executive offic...
ARCA biopharma to Present at JMP Securities Healthcare Focus Conference
BROOMFIELD, Colo., Oct. 2 /PRNewswire/ -- arca
biopharma, Inc., a
biopharmaceutical company devel...ober 6, 2008, at 3:00 p.m. EDT in New York City.
biopharma and Nuvelo, Inc. (Nasdaq: NUVO ) announ... the presentation will be available online via
biopharma website at http://www.arcabiopharma.com...
Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes
...the greatest therapeutic response to
biopharma has submitted a New Drug Application (ND... Chairman and Chief Science and Medical Officer
biopharma, said, "While currently available beta b...ians and 6.5 million annual hospital days.
ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
... BROOMFIELD, Colo., Aug. 14 /PRNewswire/ -- arca
biopharma, Inc., a
biopharmaceutical company devel.... Brewer, president and chief executive officer of arca
brings valuable experience and insight to arca
as we prepare to introduce
our first product and b...
ARCA in Biological Products
ScriptCap 2'-O-Methyltransferase from EPICENTRE Biotechnologies
Description:... improvement is seen in Cap 0 structures created by the ScriptCap m7G Capping System as well as those Cap 0 structures created using standard and arca
ARCA (Anti Reverse Cap Analog) from Ambion
Description:... only initiate transcription with the remaining hydroxyl group thus forcing arca
incorporation in the forward orientation. As a result, unlike transcripts s...ized with conventional cap analog, 100% of the transcripts synthesized with arca
at the 5 end are translatable leading to a strong stimulatory effect on tra...